Buscar
Mostrando ítems 41-50 de 1314
Prolactin (PRL) induction of cyclooxygenase 2 (COX2) expression and prostaglandin (PG) production in hamster Leydig cells
(Elsevier Ireland, 2012-01)
Serum prolactin (PRL) variations play a crucial role in the photoperiodic-induced testicular regression–recrudescence transition in hamsters. We have previously shown that cyclooxygenase 2 (COX2), a key enzyme in the ...
Coordinate regulation between the nuclear receptor peroxisome proliferator-activated receptor-γ and cyclooxygenase-2 in renal epithelial cells
(Elsevier Inc, 2014-06)
The peroxisome proliferator-activated receptors (PPARs) are ligand-dependent transcription factors involved in lipid metabolism and glucose utilization, in cell growth, differentiation and apoptosis, and in the regulation ...
Crosstalk between nitric oxide synthases and cyclooxygenase 2 in the adrenal cortex of rats under lipopolysaccharide treatment
(Springer, 2013-11)
The effect of lipopolysaccharide on the modulation of steroid production by adrenal cells has been recently acknowledged. The purpose of this study was to determine the in vivo effects of LPS on adrenal cyclooxygenase ...
Induction of redox changes, inducible nitric oxide synthase and cyclooxygenase-2 by chronic cadmium exposure in mouse peritoneal macrophages
(Elsevier Ireland, 2003-11-30)
Redox changes and the secretion of inflammatory mediators were investigated in resident peritoneal macrophages of mice chronically exposed to cadmium (Cd, 15 ppm for 2 months) through drinking water. Our results showed ...
Treatment of experimental periodontal disease by a selective inhibitor of cyclooxygenase-2 with scaling and root planing (SRP)
(2010-12-01)
Lumiracoxib is a selective inhibitor of cyclooxygenase-2 (COX-2) approved for the relief of symptoms of chronic inflammatory conditions. The aim of this study was to evaluate the effects of this specific inhibitor of COX-2 ...
Treatment of experimental periodontal disease by a selective inhibitor of cyclooxygenase-2 with scaling and root planing (SRP)
(2010-12-01)
Lumiracoxib is a selective inhibitor of cyclooxygenase-2 (COX-2) approved for the relief of symptoms of chronic inflammatory conditions. The aim of this study was to evaluate the effects of this specific inhibitor of COX-2 ...
Angioedema
(Colegio Mexicano, Asma e Inmunología Clínica A.C.Grupo de Alergología Clínica y Experimental (GACE)Tecamachalco, México, 2022)
Enhanced activation of eosinophils in peripheral blood and implications for eosinophilic esophagitis diagnosis.
(Asian Pacific Association of Gastroenterology, 2018)
Lipid Bodies Are Reservoirs of Cyclooxygenase-2 and Sites of Prostaglandin-E2 Synthesis in Colon Cancer
(American Association for Cancer Research, 2019)